Target Group Inc (CBDY)
0.0058
0.00 (0.00%)
USD |
OTCM |
Apr 26, 10:15
Target Group Cash from Operations (TTM): -0.5896M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.5896M |
September 30, 2023 | -0.8239M |
June 30, 2023 | -0.1245M |
March 31, 2023 | -1.350M |
December 31, 2022 | -1.015M |
September 30, 2022 | -0.4623M |
June 30, 2022 | -0.8275M |
March 31, 2022 | 0.1687M |
December 31, 2021 | 0.1001M |
September 30, 2021 | -0.7212M |
June 30, 2021 | -0.77M |
March 31, 2021 | -0.4837M |
December 31, 2020 | -1.433M |
September 30, 2020 | -1.304M |
June 30, 2020 | -3.528M |
March 31, 2020 | -5.266M |
December 31, 2019 | -5.515M |
September 30, 2019 | -5.242M |
June 30, 2019 | -3.511M |
Date | Value |
---|---|
March 31, 2019 | -1.764M |
December 31, 2018 | -0.6995M |
September 30, 2018 | -0.9454M |
June 30, 2018 | -0.2288M |
March 31, 2018 | -0.2462M |
December 31, 2017 | -0.2621M |
September 30, 2017 | -0.2134M |
June 30, 2017 | -0.3106M |
March 31, 2017 | -0.3815M |
December 31, 2016 | -0.421M |
September 30, 2016 | -0.4774M |
June 30, 2016 | -0.3479M |
March 31, 2016 | -0.2477M |
December 31, 2015 | -0.1924M |
September 30, 2015 | -0.163M |
June 30, 2015 | -0.136M |
March 31, 2015 | -0.0925M |
December 31, 2014 | -0.0373M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-5.515M
Minimum
Dec 2019
0.1687M
Maximum
Mar 2022
-1.721M
Average
-0.8275M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
Acasti Pharma Inc | -13.57M |
Aurinia Pharmaceuticals Inc | -33.46M |
Edesa Biotech Inc | -6.252M |
Lexaria Bioscience Corp | -5.209M |
Xenon Pharmaceuticals Inc | -145.33M |